Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Pear Therapeutics
Pear TherapeuticsPear Therapeutics Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
What is becoming different about Pear Therapeutics over time?
Movement over time
Earlier activity concentrated on workflow friction, adoption state.
Earlier period
Movement over time
More recent activity concentrates on workflow friction, time saved.
Recent period
Public evidence
PursueCare Acquires and Relaunches reSET and reSET-O Programs
SignalHunt:validation:Pear Therapeutics
Public evidence
STAT+: FDA appears open to Moderna's flu vaccine ahead of adcomm
STAT Health Tech
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 23 public external signal(s) across 10 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Pear Therapeutics through regulatory records, deployment evidence, company records and external market activity.
- Category
- clinical_documentation
What HealthAratus is still learning
HealthAratus is beginning to understand Pear Therapeutics. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Pear Therapeutics offers software-based treatments that deliver cognitive-behavioral therapy for specific health conditions. These mobile applications provide structured content for patients while offering clinicians dashboards to track treatment progress.According to Pear Therapeutics
What Pear Therapeutics states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
Clinicians can monitor patient progress through integrated software dashboards.
According to Pear Therapeutics
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported deployment
Pear Therapeutics assets sold at auction for $6.05 million following Chapter 11 bankruptcy
Reported publicly
How widely is this actually used?
Reported deployment
CodeLink Partners with Pear Therapeutics to Scale Development and Quality Assurance for reSET and reSET-O
Reported publicly
How widely is this actually used?
Reported deployment
‘We don’t think of it as just a service line’: How 5 health systems integrate behavioral health into core finances
According to Becker's Hospital Review
How widely is this actually used?
Recent change
STAT+: FDA appears open to Moderna's flu vaccine ahead of adcomm
According to STAT Health Tech
Have you noticed this shift?
Recent change
PursueCare Acquires and Relaunches reSET and reSET-O Programs
Reported publicly
A matter of record — context, not something practice can confirm.
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
- Overview: Pear Therapeutics is a pioneer in developing prescription digital therapeutics (PDTs), which are software-based treatments authorized by the FDA to address various health conditions. Their portfolio includes reSET®, reSET-O®, and Somryst®, each targeting specific disorders through evidence-based,…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings
Key strength
Regulatory: FDA authorized (De Novo)
How the reality here has changed
Earlier activity concentrated on workflow friction, adoption state. More recent activity concentrates on workflow friction, time saved.
Earlier
- workflow friction
- adoption state
More recently
- workflow friction
- time saved
Connected intelligence
Category intelligence